1973 A MULTICENTER, PLACEBO-CONTROLLED TRIAL INVESTIGATING THE SAFETY AND EFFICACY OF ONCE DAILY TADALAFIL IN MEN WITH SIGNS AND SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA TAKING CONCOMITANT A1-ADRENERGIC ANTAGONIST THERAPY

Controlled Trial ◽

Signs And Symptoms ◽

Prostatic Hyperplasia ◽

Antagonist Therapy ◽

Once Daily ◽

Safety And Efficacy ◽

Adrenergic Antagonist

Hemodynamic Effects of Once-daily Tadalafil in Men With Signs and Symptoms of Benign Prostatic Hyperplasia on Concomitant α1-Adrenergic Antagonist Therapy: Results of a Multicenter Randomized, Double-Blind, Placebo-controlled Trial

Urology ◽

10.1016/j.urology.2011.11.040 ◽

2012 ◽

Vol 79 (4) ◽

pp. 875-882 ◽

Cited By ~ 14

Author(s):

Evan Goldfischer ◽

John J. Kowalczyk ◽

William R. Clark ◽

Erin Brady ◽

Michael Anne Shane ◽

...

Keyword(s):

Controlled Trial ◽

Signs And Symptoms ◽

Prostatic Hyperplasia ◽

Hemodynamic Effects ◽

Double Blind ◽

Antagonist Therapy ◽

Once Daily ◽

Double Blind Placebo ◽

Adrenergic Antagonist

Erratum: Rapid onset of action with alfuzosin 10 mg once daily in men with benign prostatic hyperplasia: a randomized, placebo-controlled trial

Prostate Cancer and Prostatic Diseases ◽

10.1038/sj.pcan.4500981 ◽

2008 ◽

Vol 11 (2) ◽

pp. 209-209

Author(s):

M I Resnick ◽

C G Roehrborn

Keyword(s):

Controlled Trial ◽

Rapid Onset ◽

Prostatic Hyperplasia ◽

Onset Of Action ◽

471 URODYNAMIC EFFECTS OF TADALAFIL 20 MG ONCE DAILY VERSUS PLACEBO IN MEN WITH SIGNS AND SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA

European Urology Supplements ◽

10.1016/s1569-9056(09)60469-3 ◽

2009 ◽

Vol 8 (4) ◽

pp. 238 ◽

Cited By ~ 1

Author(s):

S.R. Kraus ◽

R.R. Dmochowski ◽

C.G. Roehrborn ◽

J.C. Kaminetsky ◽

L. Xu ◽

...

Keyword(s):

Signs And Symptoms ◽

Prostatic Hyperplasia ◽

Tadalafil 2.5 or 5 mg Administered Once Daily for 12 Weeks in Men with Both Erectile Dysfunction and Signs and Symptoms of Benign Prostatic Hyperplasia: Results of a Randomized, Placebo‐Controlled, Double‐Blind Study

Journal of Sexual Medicine ◽

10.1111/j.1743-6109.2011.02504.x ◽

2012 ◽

Vol 9 (1) ◽

pp. 271-281 ◽

Cited By ~ 87

Author(s):

Russell Blair Egerdie ◽

Stephen Auerbach ◽

Claus G. Roehrborn ◽

Pierre Costa ◽

Martin Sanchez Garza ◽

...

Keyword(s):

Erectile Dysfunction ◽

Signs And Symptoms ◽

Prostatic Hyperplasia ◽

Blind Study ◽

Double Blind Study ◽

Double Blind ◽

Long-Term Safety and Efficacy of a Once-Daily Formulation of Alfuzosin 10 mg in Patients with Symptomatic Benign Prostatic Hyperplasia: Open-Label Extension Study

European Urology ◽

10.1016/s0302-2838(01)00016-1 ◽

2002 ◽

Vol 41 (1) ◽

pp. 54-61 ◽

Cited By ~ 43

Author(s):

P van Kerrebroeck ◽

A Jardin ◽

P van Cangh ◽

K.U Laval

Keyword(s):

Prostatic Hyperplasia ◽

Extension Study ◽

Open Label ◽

Symptomatic Benign Prostatic Hyperplasia ◽

Once Daily ◽

Safety And Efficacy ◽

Open Label Extension

Safety and efficacy of the combination of once-daily tadalafil and alpha-1 blocker in Japanese men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A randomized, placebo-controlled, cross-over study

International Journal of Urology ◽

10.1111/iju.13357 ◽

2017 ◽

Vol 24 (7) ◽

pp. 539-547 ◽

Cited By ~ 11

Author(s):

Masayuki Takeda ◽

Osamu Yokoyama ◽

Masaki Yoshida ◽

Osamu Nishizawa ◽

Kinya Hirata ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract Symptoms ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Japanese Men ◽

Once Daily ◽

Safety And Efficacy ◽

Urinary Tract Symptoms ◽

Lower Urinary

Re: Effect of Tadalafil Once Daily on Prostate Blood Flow and Perfusion in Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Randomized, Double-Blind, Multicenter, Placebo-Controlled Trial

The Journal of Urology ◽

10.1016/j.juro.2015.02.052 ◽

2015 ◽

Vol 193 (5) ◽

pp. 1592-1594

Author(s):

Steven A. Kaplan

Keyword(s):

Blood Flow ◽

Urinary Tract ◽

Lower Urinary Tract ◽

Controlled Trial ◽

Prostatic Hyperplasia ◽

Double Blind ◽

Once Daily ◽

Urinary Tract Symptoms ◽

Lower Urinary

1370 SAFETY AND EFFICACY OF TADALAFIL 5MG DOSED ONCE DAILY IN PATIENTS ON α-BLOCKER THERAPY FOR BENIGN PROSTATIC HYPERPLASIA ACCOMPANIED BY ERECTILE DYSFUNCTION

The Journal of Urology ◽

10.1016/j.juro.2010.02.999 ◽

2010 ◽

Vol 183 (4S) ◽

Author(s):

Joo Yong Lee ◽

Seung Wook Lee ◽

Tchun Yong Lee ◽

Hae Young Park ◽

Hong Yong Choi ◽

...

Keyword(s):

Erectile Dysfunction ◽

Prostatic Hyperplasia ◽

Once Daily ◽

Blocker Therapy ◽

Safety And Efficacy

Effects of Once-Daily Tadalafil on Erectile Function in Men with Erectile Dysfunction and Signs and Symptoms of Benign Prostatic Hyperplasia

Yearbook of Urology ◽

10.1016/s0084-4071(10)79393-3 ◽

2010 ◽

Vol 2010 ◽

pp. 217-218

Author(s):

A. Shindel

Keyword(s):

Erectile Dysfunction ◽

Erectile Function ◽

Signs And Symptoms ◽

Prostatic Hyperplasia ◽

336 TADALAFIL 5 MG ONCE DAILY IMPROVES ERECTILE DYSFUNCTION (ED) AND THE SIGNS AND SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA (BPH-LUTS) IN MEN WITH BOTH ED AND BPH-LUTS: RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTINATIONAL STUDY

European Urology Supplements ◽

10.1016/s1569-9056(11)60332-1 ◽

2011 ◽

Vol 10 (2) ◽

pp. 123

Author(s):

C.G. Roehrborn ◽

R.B. Egerdie ◽

S. Auerbach ◽

P. Costa ◽

M. Sanchez Garza ◽

...

Keyword(s):

Erectile Dysfunction ◽

Signs And Symptoms ◽

Prostatic Hyperplasia ◽

Multinational Study ◽

Double Blind ◽

Once Daily ◽

Double Blind Placebo